drugset / Trial / NCT03542357

The Effect of Sumatriptan and Placebo on CGRP Induced Headache

NCT03542357

Completed 30 enrolled Danish Headache Center
RandomizedCrossoverDouble-blindTreatment

Summary

To develop a pragmatic migraine model the investigators will induce headache in healthy volunteers and in patients with migraine without aura with aCalcitonine Gene Related Peptide (CGRP). If the headache responds to sumatriptan, the model can be used to test new drug candidates.

Timeline

Start
2018-02-15
Primary completion
2018-09-01
Completion
2018-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sumatriptan Unknown 50 mg Oral

Indications